Modified Pfizer Omicron-based COVID-19 vaccine is claimed to boost the defense of the human body against the contagious variant.
Pfizer and BioNTech revealed this detail on Saturday, June 25, after they conducted some tests to check the efficiency of the updated COVID-19 medicine.
These health firms claimed that their modified vaccine actually generated a higher immune response against Omicron.
Because of this, the U.S. Food and Drug Administration announced that it would meet Pfizer and BioNTech on Tuesday, June 28, to discuss their latest findings.
Modified Pfizer Omicron-Based Vaccine Boosts Defense Against Variant?
According to Reuters' latest report, Pfizer and BioNTech used their new modified Omicron-based vaccine on around 1,200 participants aged 56 and older.
Based on their findings, the updated version of the COVID-19 medicine neutralizes the latest Omicron subvariants; BA.4 and BA.5.
As of writing, researchers said they are still collecting more data to see how well the modified vaccine boosters perform against these contagious COVID-19 variants.
"Based on these data, we believe we have two very strong omicron-adapted candidates," said Albert Bourla, the CEO of Pfizer.
Two Modification Methods
During the latest Pfizer vaccine tests, Pfizer and BioNTech studied two different modification methods to enhance their COVID-19 medicine further.
Time Magazine reported that the first method focused on making the vaccine target the Omicron variant. The second modification technique relied on a combination of the COVID-19 booster and the original version of the vaccine.
They claim that their Omicron-based COVID-19 vaccine booster has the strongest immune response against the variant. But, FDA still needs to discuss the results before the new version of the vaccine can be approved.
If you want to see further details about the new modified Pfizer vaccine, you can click this link.
On the other hand, the first North Korea COVID-19 lockdown has been confirmed.
Meanwhile, experts claimed that new COVID-19 variants would continue circulating this summer of 2022.
For more news updates about the COVID-19 vaccine and other health topics, keep your tabs open here at TechTimes.
Related Article : CanSinoBIO COVID-19 Vaccine Receives WHO Authorization After Meeting Health Standards; How Efficient Is Convidecia?
This article is owned by TechTimes
Written by: Griffin Davis
